FDA Clears First OTC Acetaminophen-Naproxen Tablet for 12-Hour Pain Relief
Updated
Updated · Consultant360 · Jul 24
FDA Clears First OTC Acetaminophen-Naproxen Tablet for 12-Hour Pain Relief
3 articles · Updated · Consultant360 · Jul 24
Summary
Tylenol with Naproxen won FDA approval on July 24 as the first over-the-counter fixed-dose tablet combining acetaminophen 325 mg and naproxen sodium 110 mg.
The product is indicated for temporary relief of minor aches and pains in adults and children 12 and older, with dosing every 12 hours for headaches, backache, muscle pain, toothache, menstrual cramps and minor arthritis pain.
FDA said the approval was backed by evidence on effectiveness and safety, but its release gave no specific trial details, study design or numerical efficacy and safety results.
Labeling warns against combining it with other acetaminophen drugs because of liver-damage risk and carries NSAID warnings on stomach bleeding and higher risks of heart attack, heart failure and stroke.
The agency called the tablet a new nonprescription option for longer-lasting pain relief, though it did not specify tablets per dose, maximum treatment duration or common adverse events.
Will Kenvue's groundbreaking single-tablet painkiller revolutionize the booming non-opioid market, or will strict safety warnings limit its widespread appeal?
Could the FDA's newly approved combo of Tylenol and naproxen unintentionally increase dual-toxicity risks for consumers seeking stronger pain relief?